ABSTRACT. Ferulic acid plays a neuroprotective role in cerebral ischemia. The aim of this study was to identify the proteins that are differentially expressed following ferulic acid treatment during ischemic brain injury using a proteomics technique. Middle cerebral artery occlusion (MCAO) was performed to induce a focal cerebral ischemic injury in adult male rats, and ferulic acid (100 mg/kg) or vehicle was administered immediately after MCAO. Brain tissues were collected 24 hr after MCAO. The proteins in the cerebral cortex were separated using two-dimensional gel electrophoresis and were identified by mass spectrometry. We detected differentially expressed proteins between vehicle-and ferulic acid-treated animals. Adenosylhomocysteinase, isocitrate dehydrogenase [NAD + ], mitogen-activated protein kinase kinase 1 and glyceraldehyde-3-phosphate dehydrogenase were decreased in the vehicle-treated group, and ferulic acid prevented the injury-induced decreases in these proteins. However, pyridoxal phosphate phosphatase and heat shock protein 60 were increased in the vehicle-treated group, while ferulic acid prevented the injury-induced increase in these proteins. It is accepted that these enzymes are involved in cellular metabolism and differentiation. Thus, these findings suggest evidence that ferulic acid plays a neuroprotective role against focal cerebral ischemia through the up-and down-modulation of specific enzymes.
Ferulic acid (4-hydroxy-3-methoxycinnamic acid) is a phenolic compound in the plant cell wall. It is known to be a free radical scavenger and to have an antioxdative effect in cerebral ischemia [4] . Ferulic acid reduces infarct volume in focal cerebral ischemia and protects neuronal cells from glutamate-induced excitotoxicity in animal models [4, 8] . It also protects neuronal cells against beta amyloid peptide toxicity and attenuates learning and memory impairment [17] . Although it has been reported that ferulic acid has a protective effect against brain ischemia, further information is needed to understand the underlying neuroprotective mechanism. We hypothesized that ferulic acid exerts a neuroprotective effect in cerebral ischemic injury by regulating the expression of various proteins. Thus, we performed 2-dimensional gel electrophoresis (2-DE) and mass spectrometry to detect the specific proteins that modulate the neuroprotective function of ferulic acid during cerebral ischemic injury.
MATERIALS AND METHODS
Experimental animals: Male Sprague-Dawley rats (220-230 g) were purchased from Samtako Co. (Animal Breeding Center, Osan, Korea). All experimental procedures for animal use were approved by the Institutional Animal Care and Use Committee at Gyeongsang National University. Animals were randomly divided into three groups: shamoperated, vehicle-treated and ferulic acid-treated (n=10 per group). Ferulic acid (100 mg/kg, Sigma, St. Louis, MO, U.S.A.) was administered as previously described [4] . Ferulic acid was dissolved in normal saline and injected intravenously immediately after middle cerebral artery occlusion (MCAO) [4] . The same volume of normal saline was given as the vehicle.
Middle cerebral artery occlusion: Animals were anesthetized with sodium pentobarbital (30 mg/kg). MCAO was performed as previously described [9] . Briefly, a 4/0 nylon suture with a rounded tip by heating was inserted into the external carotid artery through the common carotid artery and up to the internal carotid artery to block the origin of the middle cerebral artery. Animals were sacrificed 24 hr after the onset of MCAO, and brain tissues were collected.
Two-dimensional gel electrophoresis, image analysis, and protein identification: The right cerebral cortexes were homogenized in lysis buffer (8 M urea, 4% CHAPS, ampholytes, and 40 mM Tris-HCl) and centrifuged at 16,000 g for 20 min at 4°C. The immobilized pH gradient (IPG, pH 4-7, pH 6-9, 17 cm, Bio-Rad) gel strips were rehydrated in sample buffer (8 M urea, 2% CHAPS, 20 mM DTT, 0.5% IPG buffer, bromophenol blue) that sample proteins (100 µg) for 13 hr. Isoelectric focusing (IEF) was performed as follow steps: 200 V (1 hr), 500 V (1 hr), 1,000 V to 8,000 V (30 min) and 8,000 V (5 hr) using an IPG phore unit (GE Healthcare, Uppsala, Sweden). The strips were incubated with equilibration buffer and loaded on Protein-II XI electrophoresis equipment (Bio-Rad) at 10°C. Two-dimensional electrophoresis was performed at 5 mA/gel for 1 hr and then at 10 mA/gel for 10 hr at 10°C (Bio-Rad). The silver stained gels were scanned using an Agfa ARCUS 1200 TM (AgfaGevaert, Mortsel, Belsium). Scanned gel images were used to detect differentially expressed proteins between the vehicle-and ferulic acid-treated groups using PDQuest image analysis software (Bio-Rad). Selected spots were excised and destained. The gel particles were incubated with reduction solution and alkylation solution for 30 min, followed by incubation with trypsin-containing digestion buffer. The extract peptides were analyzed in a Voyager-DE TM STR Biospectrometry Workstation (Applied Biosystem, Forster city, CA, U.S.A.) for MALDI-TOF mass spectrometery. Proteins were identified using the search programs MS-Fit and ProFound. SWISS-PROT and NCBI were used as the protein sequence databases. Searching parameters were as follows: trypsin digestion with one missed cleavage, variable modifications (oxidation of methionine and carbamidomethylation of cysteine), MS mass tolerance at 50 ppm.
RNA isolation and reverse transverse-PCR amplification:
Reverse transcription was performed using reagents from Invitrogen according to the manufacturer's protocol. The primer sequences used are presented in Table 1 . The PCR reaction was carried out as follows: 5 min at 94°C, 30 sec at 94°C, 30 sec at 54°C and 1 min at 72°C, with a final extension for 10 min at 72°C. The samples were amplified for 30 cycles. PCR products were separated on 1% agarose gel and visualized under UV light.
Western blot analysis: Western blot analysis was performed as previously described with some modification [8] . Briefly, proteins (30 µg) were transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore, Billerica, MA, U.S.A.). Immunoreaction was carried out using anti-MAP kinase kinase 1, anti-60 kDa heat shock protein and antiactin (diluted 1:1,000, Cell Signaling Technology, Beverly, MA, U.S.A.). The membranes were sequentially reacted with secondary antibody (1:5,000, Pierce). The immunoreactive bands were detected by chemiluminescence using an ECL Western blot analysis system (Amersham Pharmacia Biotech, Piscataway, NJ, U.S.A.).
Data analysis: All data are expressed as means ± SEM. The intensity analysis was carried out using SigmaGel 1.0 (Jandel Scientific, San Rafael, CA, U.S.A.) and SigmaPlot 4.0 (SPSS Inc., Point Richmond, CA, U.S.A.). The results for each group were compared by one-way analysis of variance (ANOVA) followed by the Student's t-test. Differences in comparisons were considered significant at P<0.05. Figure 1 shows 2-DE images of cerebral cortex proteins of sham-operated, vehicle-treated and ferulic acid-treated animals from pH 4-7 and pH 6-9. Almost 970 proteins were detected in these groups, respectively. The intensity of 32 protein spots was found to have changed more than 2.5-fold. Among these protein spots, 25 were clearly identified by MALDI-TOF analysis with sequence coverage of 17%-62% (Table 2) . However, seven proteins were not identified and were deemed unknown proteins (Figs. 1 and 2, Table 2 ). RT-PCR analysis clearly demonstrated that the adenosylhomocysteinase, isocitrate dehydrogenase [NAD + ], MAPK kinase 1 and GAPDH levels were significantly decreased in the vehicle-treated group, whereas ferulic acid prevented the injury-induced decreases in these proteins (Fig. 3) . In contrast, pyridoxal phosphate phosphatase and heat shock protein 60 were increased in the vehicle-treated group; ferulic acid prevented the injury-induced increases in these proteins. Moreover, Western blot analysis showed that the isocitrate dehydrogenase [NAD + ], MAPK kinase 1, and GAPDH proteins levels were significantly decreased in the vehicle-treated group, whereas ferulic acid prevented these decreases. However, heat shock protein 60 protein levels were increased in the vehicle-treated group; ferulic acid prevented this increase (Fig. 3) . 5′-GGTCCCCATAGGCGTGTCG-3′
RESULTS
Mitogen-activated protein kinase kinase 1 F: 5′-TCGGACCCTTGGTACTTCAC-3′ 242 R:
5′-ACAGACTGAAGCCCCAGCTA-3′
Glyceraldehyde-3-phosphate dehydrogenase F:
5′-CGCCTGCTTCACCACCTTCTT-3′
Pyridoxal phosphate phosphatase F:
5′-AAACAATCCGCGTGTACCTC-3′
60 kDa heat shock protein F:
5′-TTGGCAATTTCAAGAGCAGG-3′_
5′-GGTCTCAAACATGATCTGGG-3′
DISCUSSION
Ferulic acid exerts an anti-oxidant effect by free radical scavenging and anti-inflammatory activity. We previously demonstrated that ferulic acid reduces infarct volume and attenuates neuronal cell death in a cerebral ischemia animal model [8] . Moreover, we identified differentially expressed proteins following ferulic acid treatment in brain ischemia using proteomics techniques. Among these identified proteins, we focus on proteins that associated with enzymes in this discussion.
Adenosylhomocysteinase is a catabolic enzyme that converts adenosylhomocysteine to adenosine and homocysteine [12] . Adenosylhomocysteinase plays a critical role in the regulation of adenosylhomocysteine levels and abundantly exists in the neocortex, hippocampus, and cerebellum [13] . Inhibition of adenosylhomocysteinase induces accumulation of intracellular adenosylhomocysteine, reduction of cellular methylation capacity and decreases in adenosine [12] . Our proteomics approach identified a decrease in adenosylhomocysteinase during MCAO-induced ischemic brain injury, and ferulic acid prevented the injury-induced decrease in adenosylhomocysteinase; the results of RT-PCR analysis clearly confirmed these findings. We can suggest that the downregulation of adenosylhomocysteinase in ischemic brain injury induces the reduction in adenosine and diminishment in neuroprotective effect. Thus, these results demonstrate that the maintenance of the adenosylhomocysteinase level Fig. 1 . Two-dimensional SDS-PAGE analysis of proteins in cerebral cortices from sham-operated (A and B), vehicletreated (C and D) and ferulic acid-treated (E and F) groups. Isoelectric focusing was performed at pH 4-7 and pH 6-9 using IPG strips, followed by second-dimensional separation on 7.5-17.5% gradient SDS gels stained with silver. Squares indicate the protein spots that were differentially expressed between the vehicle-and ferulic acid-treated groups.
by treatment with ferulic acid preserves adenosine levels and subsequently exerts neuroprotective effects during MCAO. NAD (+)-dependent isocitrate dehydrogenase is an enzyme that involved in energy metabolism [2] . Isocitrate dehydrogenase participates in the beginning of the tricarboxylic acid (TCA) cycle. Reduction of this enzyme induces the loss of ATP and impairment of energy metabolism causes the pathological changes in brain ischemia [1] . Moreover, isocitrate dehydrogenase levels are reduced in the brain tissue of Alzheimer's patients [3] . The decline in isocitrate dehydrogenase leads to a decreased ATP concentration, which causes cell death [3] . Our proteomics approach revealed that isocitrate dehydrogenase [NAD + ] is decreased upon ischemic brain injury and that ferulic acid prevents this decrease. We confirmed the expression levels of isocitrate dehydrogenase [NAD + ] in the vehicle-and ferulic acidtreated animals using RT-PCR and Western blot analyses. It is accepted that isocitrate dehydrogenase can regulate energy metabolism and determinate cell destiny. Thus, our data can suggest that maintenance of isocitrate dehydrogenase levels by ferulic acid mediates energy metabolism and cell survival in ischemic brain injury, consequentially leading to attenua- tion of cell damage. MAPKs are involved in cellular processes including proliferation, differentiation, motility, and survival [14] . An extracellular stimulus such as growth factor leads to phosphorylation of MAPK and protects neuronal cells against damage [18] . Phosphorylated MAPK kinase preserves cAMP response element binding protein phosphorylation and consequently activates anti-apoptotic proteins [11] . The maintenance of MAPK kinase is an event of the neuroprotective mechanism in ischemic brain injury. Our proteomics approach revealed that MAPK kinase 1 levels are reduced in ischemic brain injury, while ferulic acid prevents this reduction. RT-PCR and Western blot analyses clearly confirmed that ferulic acid attenuates the injury-induced decrease in MAPK kinase 1 during MCAO. These findings suggest that ferulic acid plays a protective role in ischemic brain injury through the preservation of MAPK kinase levels.
GAPDH is a glycolytic enzyme that catalyzes glycolysis and is an important component in energy metabolism. GAPDH levels slowly decrease after the release of nitric oxide during brain ischemia [10] . Brain ischemia impairs cellular energy metabolism, and the inhibition of GAPDH leads to neurodegeneration in the absence of a substitute glycolytic pathway [7] . Ultimately, downregulation of GAPDH induces damage of neuronal cells in brain injury. Our proteomic approach and RT-PCR data showed that GAPDH levels are decreased in ischemic brain injury and that ferulic acid prevents these decreases. Moreover, we confirmed the expression levels of GAPDH in the vehicle-and ferulic acid-treated animals using Western blot analysis. The maintenance of GAPDH is an important event for cellular energy metabolism and the protective mechanism in brain ischemic injury. Thus, these results suggest that ferulic acid maintains the GAPDH levels that contribute to regulating energy metabolism in brain ischemic injury and results in a nuroprotective effect.
Pyridoxal phosphate acts as a coenzyme of vitamin B6 and plays an essential role in the biosynthesis of carbohydrates, proteins, lipids and nucleic acids. A previous study showed that pyridoxal phosphate treatment reduces neuronal cell damage in ischemic injury [16] . Pyridoxal phosphate phosphatase dephosphorylates pyridoxal phosphate and degrades pyridoxal phosphate to 4-pyridoxic acid. Brain ischemic injury induced an increase in pyridoxal phosphate phosphatase expression in the hippocampal region [5] . The upregulation of pyridoxal phosphate phosphatase during ischemic injury accelerates pyridoxal phosphate degradation. Our proteomics approach and RT-PCR results indicated that pyridoxal phosphate phosphatase levels are increased during ischemic brain injury, while ferulic acid prevents this increase. The increase of pyridoxal phosphate phosphatase indicates the degradation of pyridoxal phosphate and the damage of neuronal cells in ischemic injury. Thus, our results demonstrate that the maintenance of pyridoxal phosphate phosphatase levels is a component of the neuroprotective effect of ferulic acid during MCAO injury. The inhibition of upregulation of pyridoxal phosphate phosphatase by ferulic acid contributes to the neuroprotective effect of ferulic acid during MCAO injury.
Heat shock proteins (Hsp) are involved in protein interactions such as protein folding, refolding, transport and translocation [6] . Hsp 60, which is induced by mitochondrial stress, plays an important role in mitochondrial protein folding and function [15] . Ischemic brain injury leads to intracellular aggregation of unfolded and misfolded proteins, and the accumulation of these proteins eventually triggers neuronal cell death. Previous studies showed that the mRNA and protein expression of Hsp 60 is elevated in brain ischemic injury [6] , and increased Hsp 60 expression indicates serious cell damage. Our data confirmed the fact that Hsp 60 is up-regulated after middle cerebral occlusion. Moreover, we found that ferulic acid treatment prevented the increase in Hsp60 expression using RT-PCR and Western blot analyses. Thus, the decrease in Hsp 60 induced by ferulic acid treatment indicates that ferulic acid attenuates cell damage due to focal cerebral ischemic injury.
The results of this study show that ferulic acid prevents the injury-induced reductions in adenosylhomocysteinase, isocitrate dehydrogenase [NAD + ] and GAPDH levels and that these enzymes are involved in energy metabolism. Thus, these findings suggest that ferulic acid mediates energy metabolism in ischemic brain injury and exerts a neuroprotective effect against ischemic brain injury by up-and downregulating several proteins.
